Skip to main
  1. Stocks
  2. Omada Health Inc
  3. Forecast
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 46%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is attractive because its B2B2C model through employers, health plans, and PBMs creates low customer-acquisition costs, recurring revenue, and high retention, with 90%+ customer retention and roughly 33% multi-product attach rates. The company also has a large and underpenetrated addressable market, supporting about 25M covered lives but only about 1.1M enrolled members, while GLP-1 demand, a 14% engagement lift for GLP-1 members, and 52% y/y GLP-1 billings growth reinforce near-term growth. Management’s raised long-term targets of 80% gross margin and 30% EBITDA margin, alongside a 20% revenue growth outlook and a 3x 2027 revenue valuation versus peers, suggest meaningful operating leverage and upside potential.

Bears say

Omada Health is facing a difficult competitive landscape, with benefit managers often favoring single-platform solutions yet point players and better-capitalized musculoskeletal rivals still threatening share, while regulatory burdens and virtual-only care limitations can slow adoption. Its revenue base also looks fragile because two Cigna-affiliated partners represented about 55% of 2024 revenue, making concentration risk material even though revenue rose 38% in FY24 and net revenue retention reached 128%. Although 1Q:26 showed operating expenses down about 5% year over year as a percent of revenue, long-term profitability still depends on sustained enrollment, clinical outcomes, and avoiding execution issues such as supplier disruption or cybersecurity breaches.

OMDA has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 46% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

OMDA Analyst Forecast & Price Prediction

Get the latest OMDA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in OMDA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 13 analysts, OMDA has a Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


OMDA Analyst Forecast & Price Prediction

Get the latest OMDA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in OMDA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover OMDA stock data and trends